Pricing Log in Create free account

BeyondSpring Inc. (BYSI) vs Impact Biomedical Inc. (IBO)

BeyondSpring Inc. and Impact Biomedical Inc. are both Biotechnology companies. Impact Biomedical Inc. is the larger, with a market value of $27.0M against $23.9M — 1.1× the size. BeyondSpring Inc. has negative trailing earnings, so its P/E is not meaningful; Impact Biomedical Inc. trades at 0.2×. Impact Biomedical Inc. has the higher net margin (2,254.3% vs 0.00%) and the lower return on invested capital (−22.8% vs 0.00%). Across the 14 metrics below, BeyondSpring Inc. leads on 9 and Impact Biomedical Inc. on 5.

Valuation

Metric BYSI IBO Biotechnology median
P/E n/m 0.24 8.50
P/S 17.04 653.87 9.71
P/B n/m 1.63 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 13.84 881.33 9.21
Earnings yield (46.95%) 415.59% (33.15%)
Free cash flow yield (72.94%) (2.30%) (25.50%)

Profitability

Metric BYSI IBO Biotechnology median
Gross margin 100.00% (1,111.43%) 65.16%
Operating margin 0.00% (14,600.00%) 0.00%
Net margin 0.00% 2,254.29% 0.00%
Free cash flow margin 0.00% (1,451.43%) 0.00%
Return on equity 24.96% 24.01% (56.36%)
Return on assets (29.29%) 4.41% (48.04%)
Return on invested capital 0.00% (22.81%) 0.00%

Growth

Metric BYSI IBO Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 96.30% 83.48% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BYSI IBO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.70 0.16 4.72
Net debt to EBITDA 1.42 0.00 0.96

Dividend

Metric BYSI IBO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BYSI IBO Biotechnology median
Market cap 23.93m 26.99m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack